Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on the Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia

NCT04155242 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.

NCT NCT04155242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04155242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on the Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia
Lead sponsor
University of Cambridge
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2020
Completion date
December 1, 2024
Enrollment
147 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett's oesophagus